Liver diseases are a serious health concern in the world, which requires precise and timely diagnosis to enhance the survival chances of patients. The current literature implemented numerous machine learning and deep learning models to classify liver diseases, but most of them had some issues like high misclassification error, poor interpretability, prohibitive computational expense, and lack of good preprocessing strategies. In order to address these drawbacks, we introduced StackLiverNet in this study; an interpretable stacked ensemble model tailored to the liver disease detection task. The framework uses advanced data preprocessing and feature selection technique to increase model robustness and predictive ability. Random undersampling is performed to deal with class imbalance and make the training balanced. StackLiverNet is an ensemble of several hyperparameter-optimized base classifiers, whose complementary advantages are used through a LightGBM meta-model. The provided model demonstrates excellent performance, with the testing accuracy of 99.89%, Cohen Kappa of 0.9974, and AUC of 0.9993, having only 5 misclassifications, and efficient training and inference speeds that are am
Effective public health decisions require early reliable inference of infectious disease properties. In this paper we assess the ability to infer infectious disease attributes from population-level stochastic epidemic trajectories. In particular, we construct stochastic Kermack-McKendrick model trajectories, sample them with and without observational error, and evaluate inversions for the population mean infectiousness as a function of time since infection, the infection duration distribution, and its complementary cumulative distribution, the infection survival distribution. Based on an integro-differential equation formulation we employ a natural regression approach to fit the corresponding integral kernels and show that these disease attributes are recoverable from both multi-trajectory inversions and regularized single trajectory inversions. Moreover, we demonstrate that the infection duration distribution (or alternatively the infection survival distribution) and population mean infectiousness kernel recovered can be used to solve for the individual infectiousness profile, the infectiousness of an individual over the duration of their infection, assuming that individual infect
Liver diseases pose a significant global health burden, impacting many individuals and having substantial economic and social consequences. Rising liver problems are considered a fatal disease in many countries, such as Egypt and Moldova. This study aims to develop a diagnosis and treatment model for liver disease using Basic Formal Ontology (BFO), Patient Clinical Data (PCD) ontology, and detection rules derived from a decision tree algorithm. For the development of the ontology, the National Viral Hepatitis Control Program (NVHCP) guidelines were used, which made the ontology more accurate and reliable. The Apache Jena framework uses batch processing to detect events based on these rules. Based on the event detected, queries can be directly processed using SPARQL. We convert these Decision Tree (DT) and medical guidelines-based rules into Semantic Web Rule Language (SWRL) to operationalize the ontology. Using this SWRL in the ontology to predict different types of liver disease with the help of the Pellet and Drools inference engines in Protege Tools, a total of 615 records were taken from different liver diseases. After inferring the rules, the result can be generated for the pa
Non-alcoholic fatty liver disease (NAFLD) is one of the most widespread liver disorders on a global scale, posing a significant threat of progressing to more severe conditions like nonalcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis, and hepatocellular carcinoma. Diagnosing and staging NAFLD presents challenges due to its non-specific symptoms and the invasive nature of liver biopsies. Our research introduces a novel artificial intelligence cascade model employing ensemble learning and feature fusion techniques. We developed a non-invasive, robust, and reliable diagnostic artificial intelligence tool that utilizes anthropometric and laboratory parameters, facilitating early detection and intervention in NAFLD progression. Our novel artificial intelligence achieved an 86% accuracy rate for the NASH steatosis staging task (non-NASH, steatosis grade 1, steatosis grade 2, and steatosis grade 3) and an impressive 96% AUC-ROC for distinguishing between NASH (steatosis grade 1, grade 2, and grade3) and non-NASH cases, outperforming current state-of-the-art models. This notable improvement in diagnostic performance underscores the potential application of artificial intelligence
Dermatological conditions affect 1.9 billion people globally, yet accurate diagnosis remains challenging due to limited specialist availability and complex clinical presentations. Family history significantly influences skin disease susceptibility and treatment responses, but is often underutilized in diagnostic processes. This research addresses the critical question: How can AI-powered systems integrate family history data with clinical imaging to enhance dermatological diagnosis while supporting clinical trial validation and real-world implementation? We developed a comprehensive multi-modal AI framework that combines deep learning-based image analysis with structured clinical data, including detailed family history patterns. Our approach employs interpretable convolutional neural networks integrated with clinical decision trees that incorporate hereditary risk factors. The methodology includes prospective clinical trials across diverse healthcare settings to validate AI-assisted diagnosis against traditional clinical assessment. In this work, validation was conducted with healthcare professionals to assess AI-assisted outputs against clinical expectations; prospective clinical
Liver cirrhosis is a major global health problem causing millions of deaths annually, and timely detection with aggressive treatment can significantly improve patients' quality of life. Modelling complex diseases from biomedical data is computationally challenging due to high dimensionality, strong feature correlations, noise, and limited labelled samples. Conventional Machine Learning (ML) pipelines often struggle with robustness, interpretability, and generalisation under such conditions. In this study, we propose an ML-driven multi-stage decision framework for complex disease modelling and therapeutic exploration. The framework integrates single-cell transcriptomic profiling, high-dimensional network-based feature stabilisation, multi-model learning, deep representation construction, and post-hoc decision support. Specifically, single-cell sequencing data were analysed to identify key cellular subpopulations, followed by high-dimensional weighted gene co-expression network analysis (hdWGCNA) to stabilise gene modules under sparsity and noise. To enhance non-linear feature interaction modelling, tabular molecular features were restructured into two-dimensional disease maps and an
Quantifiable image patterns associated with disease progression and treatment response are critical tools for guiding individual treatment, and for developing novel therapies. Here, we show that unsupervised machine learning can identify a pattern vocabulary of liver tissue in magnetic resonance images that quantifies treatment response in diffuse liver disease. Deep clustering networks simultaneously encode and cluster patches of medical images into a low-dimensional latent space to establish a tissue vocabulary. The resulting tissue types capture differential tissue change and its location in the liver associated with treatment response. We demonstrate the utility of the vocabulary on a randomized controlled trial cohort of non-alcoholic steatohepatitis patients. First, we use the vocabulary to compare longitudinal liver change in a placebo and a treatment cohort. Results show that the method identifies specific liver tissue change pathways associated with treatment, and enables a better separation between treatment groups than established non-imaging measures. Moreover, we show that the vocabulary can predict biopsy derived features from non-invasive imaging data. We validate th
Background: Liver diseases present a significant global health challenge and often require costly, invasive diagnostics. Electrocardiography (ECG), a widely available and non-invasive tool, can enable the detection of liver disease by capturing cardiovascular-hepatic interactions. Methods: We trained tree-based machine learning models on ECG features to detect liver diseases using two large datasets: MIMIC-IV-ECG (467,729 patients, 2008-2019) and ECG-View II (775,535 patients, 1994-2013). The task was framed as binary classification, with performance evaluated via the area under the receiver operating characteristic curve (AUROC). To improve interpretability, we applied explainability methods to identify key predictive features. Findings: The models showed strong predictive performance with good generalizability. For example, AUROCs for alcoholic liver disease (K70) were 0.8025 (95% confidence interval (CI), 0.8020-0.8035) internally and 0.7644 (95% CI, 0.7641-0.7649) externally; for hepatic failure (K72), scores were 0.7404 (95% CI, 0.7389-0.7415) and 0.7498 (95% CI, 0.7494-0.7509), respectively. The explainability analysis consistently identified age and prolonged QTc intervals (
Globally, chronic liver disease continues to be a major health concern that requires precise predictive models for prompt detection and treatment. Using the Indian Liver Patient Dataset (ILPD) from the University of California at Irvine's UCI Machine Learning Repository, a number of machine learning algorithms are investigated in this study. The main focus of our research is this dataset, which includes the medical records of 583 patients, 416 of whom have been diagnosed with liver disease and 167 of whom have not. There are several aspects to this work, including feature extraction and dimensionality reduction methods like Linear Discriminant Analysis (LDA), Factor Analysis (FA), t-distributed Stochastic Neighbour Embedding (t-SNE), and Uniform Manifold Approximation and Projection (UMAP). The purpose of the study is to investigate how well these approaches work for converting high-dimensional datasets and improving prediction accuracy. To assess the prediction ability of the improved models, a number of classification methods were used, such as Multi-layer Perceptron, Random Forest, K-nearest neighbours, and Logistic Regression. Remarkably, the improved models performed admirably
Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disorder characterized by the excessive accumulation of fat in the liver in individuals who do not consume significant amounts of alcohol, including risk factors like obesity, insulin resistance, type 2 diabetes, etc. We aim to identify subgroups of NAFLD patients based on demographic, clinical, and genetic characteristics for precision medicine. The genomic and phenotypic data (3,408 cases and 4,739 controls) for this study were gathered from participants in Mayo Clinic Tapestry Study (IRB#19-000001) and their electric health records, including their demographic, clinical, and comorbidity data, and the genotype information through whole exome sequencing performed at Helix using the Exome+$^\circledR$ Assay according to standard procedure (www$.$helix$.$com). Factors highly relevant to NAFLD were determined by the chi-square test and stepwise backward-forward regression model. Latent class analysis (LCA) was performed on NAFLD cases using significant indicator variables to identify subgroups. The optimal clustering revealed 5 latent subgroups from 2,013 NAFLD patients (mean age 60.6 years and 62.1% women), while
Differentiating non-alcoholic steatohepatitis (NASH) from non-alcoholic fatty liver disease (NAFLD) using ultrasound remains challenging due to subtle tissue alterations and the limited information available in conventional B-mode imaging. In this work, we investigate whether complementary ultrasound representations derived from the same acquisition can improve NASH versus NAFLD classification. Specifically, we combine conventional B-mode ultrasound with physics-guided and local phase-based image representations and evaluate their effectiveness using self-supervised masked autoencoders (MAEs) and graph convolutional networks (GCNs). Experiments were conducted on a multi-site Mayo Clinic cohort consisting of 2,547 liver ultrasound scans from 125 patients. Compared with conventional B-mode ultrasound alone, complementary ultrasound representations consistently improved classification performance, yielding gains of up to 32.4% in accuracy and 91.2% in F1-score. Furthermore, performance improvements were consistently observed across age groups, sex, race, ethnicity,and acquisition sites.
We seek to identify genes involved in Parkinson's Disease (PD) by combining information across different experiment types. Each experiment, taken individually, may contain too little information to distinguish some important genes from incidental ones. However, when experiments are combined using the proposed statistical framework, additional power emerges. The fundamental building block of the family of statistical models that we propose is a hierarchical three-group mixture of distributions. Each gene is modeled probabilistically as belonging to either a null group that is unassociated with PD, a deleterious group, or a beneficial group. This three-group formalism has two key features. By apportioning prior probability of group assignments with a Dirichlet distribution, the resultant posterior group probabilities automatically account for the multiplicity inherent in analyzing many genes simultaneously. By building models for experimental outcomes conditionally on the group labels, any number of data modalities may be combined in a single coherent probability model, allowing information sharing across experiment types. These two features result in parsimonious inference with few
Chronic liver disease represents a significant health challenge worldwide and accurate prognostic evaluations are essential for personalized treatment plans. Recent evidence suggests that integrating multimodal data, such as computed tomography imaging, radiomic features, and clinical information, can provide more comprehensive prognostic information. However, modalities have an inherent heterogeneity, and incorporating additional modalities may exacerbate the challenges of heterogeneous data fusion. Moreover, existing multimodal fusion methods often struggle to adapt to richer medical modalities, making it difficult to capture inter-modal relationships. To overcome these limitations, We present the Triple-Modal Interaction Chronic Liver Network (TMI-CLNet). Specifically, we develop an Intra-Modality Aggregation module and a Triple-Modal Cross-Attention Fusion module, which are designed to eliminate intra-modality redundancy and extract cross-modal information, respectively. Furthermore, we design a Triple-Modal Feature Fusion loss function to align feature representations across modalities. Extensive experiments on the liver prognosis dataset demonstrate that our approach signific
Background: We aimed to quantify hepatic vessel volumes across chronic liver disease stages and healthy controls using deep learning-based magnetic resonance imaging (MRI) analysis, and assess correlations with biomarkers for liver (dys)function and fibrosis/portal hypertension. Methods: We assessed retrospectively healthy controls, non-advanced and advanced chronic liver disease (ACLD) patients using a 3D U-Net model for hepatic vessel segmentation on portal venous phase gadoxetic acid-enhanced 3-T MRI. Total (TVVR), hepatic (HVVR), and intrahepatic portal vein-to-volume ratios (PVVR) were compared between groups and correlated with: albumin-bilirubin (ALBI) and model for end-stage liver disease-sodium (MELD-Na) score, and fibrosis/portal hypertension (Fibrosis-4 [FIB-4] score, liver stiffness measurement [LSM], hepatic venous pressure gradient [HVPG], platelet count [PLT], and spleen volume). Results: We included 197 subjects, aged 54.9 $\pm$ 13.8 years (mean $\pm$ standard deviation), 111 males (56.3\%): 35 healthy controls, 44 non-ACLD, and 118 ACLD patients. TVVR and HVVR were highest in controls (3.9; 2.1), intermediate in non-ACLD (2.8; 1.7), and lowest in ACLD patients (2.3
Liver cancer is a leading cause of mortality worldwide, and accurate Computed Tomography (CT)-based tumor segmentation is essential for diagnosis and treatment. Manual delineation is time-intensive, prone to variability, and highlights the need for reliable automation. While deep learning has shown promise for automated liver segmentation, precise liver tumor segmentation remains challenging due to the heterogeneous nature of tumors, imprecise tumor margins, and limited labeled data. We present SmoothSegNet, a novel deep learning framework that addresses these challenges with the three key designs: (1) A novel knowledge-informed label smoothing technique that distills knowledge from clinical data to generate smooth labels, which are used to regularize model training, reducing the overfitting risk and enhancing model performance; (2) A global and local segmentation framework that breaks down the main task into two simpler sub-tasks, allowing optimized preprocessing and training for each; and (3) Pre- and post-processing pipelines customized to the challenges of each subtask aimed to enhance tumor visibility and refines tumor boundaries. We apply the proposed model on a challenging H
Objectives: The role of advanced diffusion-weighted imaging (DWI) in chronic liver disease (CLD) has not been fully studied. Chronic liver disease (CLD) is a progressive deterioration of liver functions, caused by one or more etiology. This study was aimed to investigate whether radiomics features extracted from individual or combined magnetic resonance imaging sequences, such as T1-weighted, T2-weighted images, or quantitative maps from chemical shift encoded, diffusion-weighted imaging, can effectively classify inflammation and fibrosis in CLD. Method: Seventy-seven patients with CLD were enrolled in this study. Each participant underwent both MRI examinations and liver biopsy. The biopsy procedure was applied to quantitatively or semi-qualitatively analyze several histology features, steatosis, inflammation, and fibrosis. Radiomic features were extracted, selected, reduced, and used to train the inflammation and fibrosis classification based on random forest models. The performances of classifiers were evaluated by the receiver operating characteristic curve (ROC), accuracy, precision, sensitivity, specificity, and DeLong tests. Result: The random forest model achieved the area
INTRODUCTION: Alzheimer's disease (AD) is genetically complex, complicating robust classification from genomic data. METHODS: We developed a transformer-based ensemble model (TrUE-Net) using Monte Carlo Dropout for uncertainty estimation in AD classification from whole-genome sequencing (WGS). We combined a transformer that preserves single-nucleotide polymorphism (SNP) sequence structure with a concurrent random forest using flattened genotypes. An uncertainty threshold separated samples into an uncertain (high-variance) group and a more certain (low-variance) group. RESULTS: We analyzed 1050 individuals, holding out half for testing. Overall accuracy and area under the receiver operating characteristic (ROC) curve (AUC) were 0.6514 and 0.6636, respectively. Excluding the uncertain group improved accuracy from 0.6263 to 0.7287 (10.24% increase) and F1 from 0.5843 to 0.8205 (23.62% increase). DISCUSSION: Monte Carlo Dropout-driven uncertainty helps identify ambiguous cases that may require further clinical evaluation, thus improving reliability in AD genomic classification.
Addressing the challenge of limited labeled data in clinical settings, particularly in the prediction of fatty liver disease, this study explores the potential of graph representation learning within a semi-supervised learning framework. Leveraging graph neural networks (GNNs), our approach constructs a subject similarity graph to identify risk patterns from health checkup data. The effectiveness of various GNN approaches in this context is demonstrated, even with minimal labeled samples. Central to our methodology is the inclusion of human-centric explanations through explainable GNNs, providing personalized feature importance scores for enhanced interpretability and clinical relevance, thereby underscoring the potential of our approach in advancing healthcare practices with a keen focus on graph representation learning and human-centric explanation.
Disease Intelligence (DI) is based on the acquisition and aggregation of fragmented knowledge of diseases at multiple sources all over the world to provide valuable information to doctors, researchers and information seeking community. Some diseases have their own characteristics changed rapidly at different places of the world and are reported on documents as unrelated and heterogeneous information which may be going unnoticed and may not be quickly available. This research presents an Ontology based theoretical framework in the context of medical intelligence and country/region. Ontology is designed for storing information about rapidly spreading and changing diseases with incorporating existing disease taxonomies to genetic information of both humans and infectious organisms. It further maps disease symptoms to diseases and drug effects to disease symptoms. The machine understandable disease ontology represented as a website thus allows the drug effects to be evaluated on disease symptoms and exposes genetic involvements in the human diseases. Infectious agents which have no known place in an existing classification but have data on genetics would still be identified as organism
End-Stage Liver Disease (ESLD), a complex condition, has high rates of co-occurring comorbidities affecting multiple organ systems. There is no clear evidence-based practice (EBP) guidelines addressing the progression of comorbidities in ESLD patients awaiting liver transplantation (LT) and their impact on survival, both pre- and post-transplant. This study aimed to identify and quantify the trajectory of the most common and deteriorating comorbidities in ESLD patients awaiting LT and to analyze their effect on patient outcomes. An initial exploratory phase to identify frequent comorbidities in ESLD patients. Relevant EBP-driven data for diagnosing and measuring the progression of these conditions were collected and organized into five research matrices. In the quantitative phase, a retrospective analysis was conducted using longitudinal de-identified data from electronic health records (EHR) for patients who underwent LT between 2011-2021. Data included demographics, labs, procedures, and medications. Descriptive statistics and survival analysis assessed the association of comorbidities with post-transplant survival. The five most frequent comorbidities identified were Diabetes Me